Clinicopathological outline of dementia with Lewy bodies applying the revised criteria: The Hisayama study

Brain Pathology

Volumn 18, Issue 3, 2008, Pages 317-325

  Fujimi, Kouhei ^a,b   Sasaki, Kensuke ^a,b   Noda, Kazuhito ^a,b   Wakisaka, Yoshinobu ^a,b   Tanizaki, Yumihiro ^a,b   Matsui, Yukiko ^a,b   Sekita, Atsuko ^a,b   Iida, Mitsuo ^a,b   Kiyohara, Yutaka ^a,b   Kanba, Shigenobu ^a,b   Iwaki, Toru ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b KURUME UNIVERSITY   (Japan)

Author keywords

Dementia; Diagnosis; DLB; Lewy body; Pathology

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; BRAIN STEM; CLINICAL ASSESSMENT; CLINICAL FEATURE; DEMENTIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEWY BODY; NEUROPATHOLOGY; PREVALENCE;

AGED; AGED, 80 AND OVER; BRAIN; FEMALE; HUMANS; LEWY BODY DISEASE; MALE; NEUROPSYCHOLOGICAL TESTS;

EID: 44649197706     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2008.00169.x     Document Type: Article

References (39)

1. Anonymous (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 18 (Suppl.4 S1 S2.
2. Anonymous (2001) Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 357 : 169 175.
3. Association AP (1987) Diagnositic and Statistical Manual of Mental Disorders, 3rd edn., revised. American Psychiatric Association : Washington, DC.
4. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM et al (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152 : 879 884.
5. Ballard C, McKeith I, Burn D, Harrison R, O'Brien J, Lowery K et al (1997) The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies. Acta Neurol Scand 96 : 366 371.
6. Ballard C, Ziabreva I, Perry R, Larsen JP, O'Brien J, McKeith I et al (2006) Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 67 : 1931 1934.
7. Ballard CG, Jacoby R, Del Ser T, Khan MN, Munoz DG, Holmes C et al (2004) Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies. Am J Psychiat 161 : 843 849.
8. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112 : 389 404.
9. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82 : 239 259.
10. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 44 : 2308 2314.
11. Del Ser T, Hachinski V, Merskey H, Munoz DG (2001) Clinical and pathologic features of two groups of patients with dementia with Lewy bodies: Effect of coexisting Alzheimer-type lesion load. Alz Dis Assoc Dis 15 : 31 44.
12. Dickson DW, Ruan D, Crystal H, Mark MH, Davies P, Kress Y et al (1991) Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: Light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology 41 : 1402 1409.
13. Fujimi K, Noda K, Sasaki K, Wakisaka Y, Tanizaki Y, Iida M et al (2007) Altered expression of COX-2 in subdivisions of the hippocampus during aging and in Alzheimer's disease: The Hisayama study. Dement Geriatr Cogn 23 : 423 431.
14. Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosur Ps 51 : 745 752.
15. Hamilton RL (2000) Lewy bodies in Alzheimer's disease: A neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol 10 : 378 384.
16. Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R et al (1990) The Lewy body variant of Alzheimer's disease: A clinical and pathologic entity. Neurology 40 : 1 8.
17. Katsuki S (1966) Epidemiological and clinicopathological study on cerebrovascular disease in Japan. Prog Brain Res 21 : 64 89.
18. Kiyohara Y, Yoshitake T, Kato I, Ohmura T, Kawano H, Ueda K et al (1994) Changing patterns in the prevalence of dementia in a Japanese community: the Hisayama study. Gerontology 40 (Suppl.2 29 35. JHR, Tsuang DW, Schantz A, Vavrek D, Larson EB, Kukull WA et al (2008) Empiric refinement of the pathologic assessment of lewy-related pathology in the dementia patient. Brain Pathol 18 : 220 224.
19. Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I et al (2003) Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18 : 467 486.
20. Lopez OL, Becker JT, Sweet RA, Martin-Sanchez FJ, Hamilton RL (2006) Lewy bodies in the amygdala increase risk for major depression in subjects with Alzheimer disease. Neurology 67 : 660 665.
21. McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J et al (2004) Dementia with Lewy bodies. Lancet Neurol 3 : 19 28.
22. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65 : 1863 1872.
23. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of theconsortium on DLB international workshop. Neurology 47 : 1113 1124.
24. McKeith IG, Perry EK, Perry RH (1999) Report of the second dementia with Lewy body international workshop: Diagnosis and treatment. Consortium on Dementia with Lewy Bodies. Neurology 53 : 902 905.
25. Merdes AR, Hansen LA, Jeste DV, Galasko D, Hofstetter CR, Ho GJ et al (2003) Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology 60 : 1586 1590.
26. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 : 479 486.
27. Noda K, Sasaki K, Fujimi K, Wakisaka Y, Tanizaki Y, Wakugawa Y et al (2006) Quantitative analysis of neurofibrillary pathology in a general population to reappraise neuropathological criteria for senile dementia of the neurofibrillary tangle type (tangle-only dementia): The Hisayama Study. Neuropathology 26 : 508 518.
28. Parkkinen L, Soininen H, Laakso M, Alafuzoff I (2001) Alpha-synuclein pathology is highly dependent on the case selection. Neuropathol Appl Neurobiol 27 : 314 325.
29. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Sci 276 : 2045 2047.
30. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH et al (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43 : 250 260.
31. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388 : 839 840.
32. Taki J, Yoshita M, Yamada M, Tonami N (2004) Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: It can be a specific marker for Lewy body disease. Ann Nucl Med 18 : 453 461.
33. Tanizaki Y, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Shinohara N et al (2000) Incidence and risk factors for subtypes of cerebral infarction in a general population: The Hisayama study. Stroke 31 : 2616 2622.
34. Uchikado H, Lin W, DeLucia M, Dickson D (2006) Alzheimer disease with amygdala Lewy bodies: A distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 65 : 685 697.
35. Wakisaka Y, Furuta A, Tanizaki Y, Kiyohara Y, Iida M, Iwaki T (2003) Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study. Acta Neuropathol 106 : 374 382.
36. Walker MP, Ayre GA, Cummings JL, Wesnes K, McKeith IG, O'Brien JT, Ballard CG (2000) The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia. Br J Psychiatry 177 : 252 256.
37. Weiner MF, Risser RC, Cullum CM, Honig L, White C, 3rd., Speciale S et al (1996) Alzheimer's disease and its Lewy body variant: A clinical analysis of postmortem verified cases. Am J Psychiatry 153 : 1269 1273.
38. Yoshitake T, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K et al (1995) Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 45 : 1161 1168.
39. Zaccai J, McCracken C, Brayne C (2005) A systematic review of prevalence and incidence studies of dementia with Lewy bodies. Age Ageing 34 : 561 566.